While others were watching the Life Sciences boom, Rupa was already constructing its laboratory.
Every generation has a sector that defines it. In the 1990s, it was commercial real estate. Rupa was there. In the 2000s, it was integrated office parks. Rupa was there. In the 2010s, it was hospitality and mixed-use development. Rupa was there. In the 2020s, it is Life Sciences. Rupa is already there.
This is not a pivot. This is a pattern — the pattern of a group that has never waited for a market to mature before building for it. The group that sees where a city is going and has the foundations poured before anyone else has finished the feasibility study.
India is one of the fastest growing Life Sciences markets in the world. The sector is poised for multi-fold growth by 2030 — driven by a rising population, increasing life expectancy, a powerful industrial base and a government that has finally understood what the pharmaceutical and research community needs.
What it needs, above all else, is infrastructure worthy of the science being conducted inside it. That is where Rupa arrives. As it always has — precisely, purposefully, and ahead of schedule.
The building should fit around the science. That is what we built.
"The future of India's pharmaceutical industry needs a place to work. We built it in Navi Mumbai. We built it first."
Explore built-to-suit laboratory and R&D facilities at Rupa Galaxy D198.
ENQUIRE NOW